Member Info for stt1

Blackrhino,

"If this gets taken out it will not be in the 20s"

The company broker and NOMAD, Liberum, themselves have a target price in the mid 20s. With that target, they also compare HVO to their nearest UK peer Ergomed.

Therefore, if there was a takeover offer then the NOMAD is likely to advise the company that it's a fair offer.

The NOMAD have already stated a target of mid 20s whilst comparing it to Ergomed.

Ergomed was taken over with a 28% premium.

HVO's own company broker, Liberum, sees Ergomed as the closest UK Peer.

Yet with that comparison in mind, their price target for HVO is 26.6p. IF HVO receives a similar premium as Ergomed did then HVO's takeover would be around Liberum's target price, mid 20s.

"After today's upgrades, the shares trade on just 9.3x EV/ 2023 EBITDA and look materially undervalued, particularly against the recently announced 21x takeout EV/ 2023 EBITDA multiple for its closest UK peer, Ergomed. We remain buyers with a new target price of 26.60p."

Moniman,

"companies have over £30 million in the bank "

If they have so much spare money in the bank then why not pay a proper dividend? They are paying a nominal dividend, which will be decided when they announce their fy2023 results, so still around 6 months to go and more until it is paid.

Why not they prepared to pay a proper dividend this year for fy2022 or H1 2023?

Why didn't they pay for the new facility out of the huge cash they hold? This would prevent clients who largely paid for the new facility from having preferential treatment over potential new clients?

The dividend is being paid just months before MO's huge options are due to be exercised.

Best to do your own research than believe the misleading (and lies) of some.

Where is there only 1 customer?

FACTS

TLY has a diversified business model covering Urgent Care, Elective Care and Corporate Wellbeing. Their services are to NHS, HMP and Corporations.

They provide their services in ALL 4 UK Nations and Republic of Ireland.

As far as I'm aware, Republic of Ireland is a separate sovereign country and not ruled by the UK Govn.

;-)

"Totally addresses the challenges of increased demand on healthcare services by delivering high quality urgent care, elective care and outpatient services across the UK and Ireland."

"Through Energy Fitness Professionals, Totally also offers corporate customers a range of fitness and wellbeing services, either within their offices or through digital channels, promoting a physically and mentally fit workforce. "

https://www.totallyplc.com/our-services/

Greend,

"1. Agree that a more aggressive revenue growth would be preferable, but think that has been constrained by operational factors in the main. However, if they can see another 12% next FY, that would see them to c £62mn from organic growth."

Point is the timing is too much of coincidence with MOs huge 7m options.

The expectation of £50m for fy2023 was made 2 years ago. Given they knew they were constrained by the facility 2 years ago then why didn't they take action back then.

MO was appointed CEO in Feb 2022 and he knew about the constraints. Yet he was awarded his huge options this Feb (backdated by a year). The new facilities will be ready Q1 24. The intended nominal divi as well will be announced and paid as part of fy23 results.

Nominal divi and new facility both planned for fy2024, just months before MOs huge options can be exercised.

Whereas both could have been planned for this fy.

" Private Equity firm Permira deemed Ergomed sufficiently valuable to purchase at a PE of x45"

Ergomed was taken over with a 28% premium.

HVO's own company broker, Liberum, sees Ergomed as the closest UK Peer.

Yet with that comparison in mind, their price target for HVO is 26.6p. IF HVO receives a similar premium as Ergomed did then HVO's takeover would be around Liberum's target price, mid 20s.

"After today's upgrades, the shares trade on just 9.3x EV/ 2023 EBITDA and look materially undervalued, particularly against the recently announced 21x takeout EV/ 2023 EBITDA multiple for its closest UK peer, Ergomed. We remain buyers with a new target price of 26.60p."

Wow, sp dips and all the posters, who were posting throughout the day, gone as well... coincidence? lol

Roley,

"with the new facilities kicking in for 2024 and beyond."

What is the revenue expectation for fy2024?

Regarding the new facility. It was largely paid for by clients, so those clients will have favourable treatment/preference over potential new clients. Those potential new clients will have to wait or they could walk away.

Green,

"like for like £56.5m…"

Whether it's £50m without r&d credits or £56.5m, the point is where's the significant growth?

Compare that to the previous years when revenue growth was growing strongly.

fy2021 £39m

fy2022 £50m

efy2023 £55m/£57m (without r&d, with r&d)

Revenue growth has slowed.

Roley

"increasing your revenue guidance is a very positive thing especially as margin is forecast to also increase."

fy2022 £50m

efy2023 £55m

That's an increase in revenue of only £5m, or 10%, compared to last year, fy2022.

They supposed to be a rapidly growing company, yet revenue growth has stalled.

"hVIVO increases its revenue guidance to £55 million (excluding other income) for 2023 "

https://polaris.brighterir.com/public/hvivo/news/rns/story/rgz9g3w

Noelpro

The £55m is the company's expectation for fy2023 - from their H1 results from only 2 weeks ago.

"hVIVO increases its revenue guidance to £55 million (excluding other income) for 2023"

https://polaris.brighterir.com/public/hvivo/news/rns/story/rgz9g3w

Kingy,

"HVIVO is Un -borrowable from anyone ".

Really.

The facts say different.

The Shares on Loan, Euroclear, website is free to register or login as guest.

2022

Apr nil

Sep nil

Oct 10904025 1.81%

Dec 11776718 1.95%

2023

Jan 11807363 1.96%

Mar 10343216 1.7%

May 7711945 1.19%

Jun 11313693 1.73%

Aug 10760207 1.65%

https://my.euroclear.com/apps/en/monthly-stock-loan-data.html#month=eq:9&year=eq:2023&limit=0&search=1

Free to register or login as guest

So...

There were nil shares on loan when MO took over then surged to avg around 11m EVERY month for over the past year.

The Shares on Loan dipped for only 1 month just before fy2022 results and then surged after fy2022 results.

Why they surged a few months after MO took over as CEO?

Why they dipped just before last year's results and then surged again post the results?

I think that was because investors didn't get the good results they were hoping for.

Moniman

"will be interesting to see where it goes if II's start coming on board over the next few months. "

The thread title is "Stake Building"...

Whatever happened to large trades shows the IIs have been coming on board over the past few weeks and are coming on board NOW, with the thread title "Stake building"!!!

Now you're now saying IF IIs START coming on board over the next FEW months!!!

So it's now a maybe, IF, hopefully

;-)

UH,

"you seem to commenting as if you're a shareholder"

He's obviously pulling the wool over reader's eyes about holding and selling.

He claimed earlier at 13.31 that he wished he made the move to HVO a year ago.

Yet 2years ago, he was ramping them as ORPH(renamed to HVO since) when the sp was around 25p.

https://www.lse.co.uk/profiles/hallsworthy/?page=15

Halls,

"Remind me how many customers TLY have? "

That comment shows you know nothing about the business model.

They have dozens of customers, from national NHS to local health authorities to GPs.

Each UK Nation has it's own NHS system.

Corporations who use the Corporate Wellbeing services.

HMP - Prison service.

Republic of Ireland

https://www.totallygroup.com/news-and-media/news/totally-healthcare-awarded-key-new-contract-republic-ireland/

TLY provide their services in all 4 UK Nations AND republic of Ireland.

FACTS:

fy2022 £50m

efy2023 £55m

efy2024 £59m

So, where's the substantial revenue growth.

Fy2023:

H1 2023: fy2022 £50m to fy2023 guidance £55m - that's around 10-11%

"hVIVO increases its revenue guidance to GBP55 million (excluding other income) for 2023"

https://polaris.brighterir.com/public/hvivo/news/rns/story/rgz9g3w

fy24:

Brokers expecting £59m

So even with the new facility up and running in Q1 2024, they expect revenue to increase by only £4m for fy2024. Really?

Kilman,

"" Revenues expected to hit 90m by 2025 and with increasing margins we will hit ATH by then.""

"Halls where was that revenue figure stated? I've only seen a €59m figure from Finncap for 2024."

I haven't seen £90m by 2025 in any official release. Maybe the rampers would post a link to it.

Adzy,

Best to read the company newsflow.

I also mentioned the red flags on trmr & Byot, when the sp there was surging to 850p and 10p respectively. The sp crashed to current 140p and 1.4p respectively due to the red flags I warned about.

Byot:

https://www.lse.co.uk/ShareChat.html?ShareTicker=BYOT&share=Byotrol&page=5

trmr:

https://www.lse.co.uk/ShareChat.html?ShareTicker=TRMR&share=Tremor&page=18

Moniman,

"Sicko will no doubt be crying all the way up to 30p! "

You mean the sp will go higher than the company broker's target?

Obviously you're backing your conviction and loading up at 20p and won't be selling until they by-pass 30p, aren't you?

Or are you just ramping and hoping some gullible readers believe the rampers and buy in and push the sp higher, so you can sell???

Hallsworthy,

" I've pulled out what little I have left and invested it in HVO instead,"

You mean HVO where the CEO was the only BoD awarded a huge 7m options, where there's questionable business model, questionable history.

Best read the company (HVO/ORPH) newsflow there - the red flags are so obvious and it's obviously being pumped.

There's a large number of Shares On Loan.

There were nil shares on loan when MO took over then avg around 11m over the past year. The Shares on Loan dipped for only 1 month just before fy results and then surged after fy results.

Why they surged a few months after MO took over as CEO?

Why they dipped just before last year's results and then surged again post the results?

I think that was because investors didn't get the good results they were hoping for.

Evidence - see for yourselves:

The Shares on Loan, Euroclear, website is free to register or login as guest.

2022

Apr nil

Sep nil

Oct 10904025 1.81%

Dec 11776718 1.95%

2023

Jan 11807363 1.96%

Mar 10343216 1.7%

May 7711945 1.19%

Jun 11313693 1.73%

Aug 10760207 1.65%

https://my.euroclear.com/apps/en/monthly-stock-loan-data.html#month=eq:9&year=eq:2023&limit=0&search=1

Free to register or login as guest

Where is there 3m bought?

They late trades from yesterday.

Better to talk about the trades than the company news and fundamentals. lol